BRPI0909692A2 - inibidor da elevação do nível de fosfóro no sangue - Google Patents

inibidor da elevação do nível de fosfóro no sangue

Info

Publication number: BRPI0909692A2
Authority: BR; Brazil
Prior art keywords: blood; depressant; phosphorus concentration; concentration rise; level elevation
Prior art date: 2008-03-19

Application number

BRPI0909692-2A

Other languages

English (en)

Japanese (ja)

Inventor

Asada Masanori

Kanaya Tadashi

Ogawa Tetsuya

Shimada Mikiko

Uehara Yumi

Original Assignee

Morishita Jintan Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-19

Filing date

2009-03-02

Publication date

2018-06-26

2009-03-02 Application filed by Morishita Jintan Co., Ltd. filed Critical Morishita Jintan Co., Ltd.

2018-06-26 Publication of BRPI0909692A2 publication Critical patent/BRPI0909692A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Botany (AREA)
Zoology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Oncology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0909692-2A 2008-03-19 2009-03-02 inibidor da elevação do nível de fosfóro no sangue BRPI0909692A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2008-072218		2008-03-19
JP2008072218A JP5487379B2 (ja)	2008-03-19	2008-03-19	血中リン濃度上昇抑制剤
PCT/JP2009/053837 WO2009116382A1 (ja)	2008-03-19	2009-03-02	血中リン濃度上昇抑制剤

Publications (1)

Publication Number	Publication Date
BRPI0909692A2 true BRPI0909692A2 (pt)	2018-06-26

Family

ID=41090788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0909692-2A BRPI0909692A2 (pt)	2008-03-19	2009-03-02	inibidor da elevação do nível de fosfóro no sangue

Country Status (10)

Country	Link
US (2)	US20110002902A1 (pt)
EP (1)	EP2281567B1 (pt)
JP (2)	JP5487379B2 (pt)
KR (1)	KR101657066B1 (pt)
CN (1)	CN101977615B (pt)
BR (1)	BRPI0909692A2 (pt)
CA (1)	CA2716676C (pt)
ES (1)	ES2443293T3 (pt)
TW (1)	TWI489987B (pt)
WO (1)	WO2009116382A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5087167B2 (ja) *	2010-12-28	2012-11-28	フロイント産業株式会社	ビフィズス菌大腸デリバリーカプセル及びその製造方法
JP6297441B2 (ja) *	2014-07-31	2018-03-20	森永乳業株式会社	ビフィドバクテリウム属細菌含有カプセルおよびその製造方法
JP5989953B1 (ja) *	2015-12-28	2016-09-07	森下仁丹株式会社	粉末状成分含有シームレスカプセルおよびその製造方法
KR101684289B1 (ko) *	2016-05-17	2016-12-09	한국식품연구원	락토바실러스 sp. KCCM 11826P 균주를 이용한 고인산혈증 예방, 만성 신장질환 치료용 약학조성물 및 건강기능성 식품
WO2019111398A1 (ja) *	2017-12-08	2019-06-13	森下仁丹株式会社	非水素添加油脂で構成された三層構造カプセルおよびその製造方法
CN112203668B (zh)	2017-12-15	2024-02-06	绿十字生命健康有限公司	用于抑制和预防肾病发展的益生菌和包含其的用于抑制和预防肾病发展的组合物
JP7303221B2 (ja)	2018-03-15	2023-07-04	アール．ピー．シェーラーテクノロジーズ，エルエルシー	腸溶性ソフトゲルカプセル剤
JP7515153B2 (ja) *	2020-03-06	2024-07-12	学校法人麻布獣医学園	乳酸菌含有組成物
US11541085B2 (en)	2020-09-29	2023-01-03	Chambio Co., Ltd.	Postbiotic extract and preparation process and use thereof
US11517596B2 (en) *	2020-09-29	2022-12-06	Chambioco., Ltd.	Method for alleviating arthritis with postbiotic extract
JP2023179810A (ja) *	2020-11-13	2023-12-20	味の素株式会社	ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法
KR102823070B1 (ko)	2024-10-17	2025-06-23	주식회사 리스큐어바이오사이언시스	인산 흡수능이 우수한 락티플랜티바실러스 파라플란타룸 lbmb320502 균주 및 이를 포함하는 고인산혈증 또는 만성신장질환-미네랄골질환의 예방, 개선 또는 치료용 조성물
KR102794667B1 (ko)	2024-10-17	2025-04-16	주식회사 리스큐어바이오사이언시스	인산 흡수능이 우수한 락티카제이바실러스 파라카제이 아종 톨러란스 균주 및 이를 포함하는 고인산혈증 또는 만성신장질환-미네랄골질환의 예방, 개선 또는 치료용 조성물
KR102794670B1 (ko)	2024-10-17	2025-04-16	주식회사 리스큐어바이오사이언시스	인산 흡수능이 우수한 슐레이페릴락토바실러스 하비넨시스 lbmb321214 균주 및 이를 포함하는 고인산혈증 또는 만성신장질환-미네랄골질환의 예방, 개선 또는 치료용 조성물
KR102824058B1 (ko)	2024-10-17	2025-06-24	주식회사 리스큐어바이오사이언시스	인산 흡수능이 우수한 페디오코쿠스 펜토사세우스 lbmb320801 균주 및 이를 포함하는 고인산혈증 또는 만성신장질환-미네랄골질환의 예방, 개선 또는 치료용 조성물
KR102857812B1 (ko) *	2025-05-16	2025-09-11	주식회사 리스큐어바이오사이언시스	체내 요독물질 배출 또는 감소, 및 항염증 활성이 우수한 락토코커스 락티스 아종 호르드니아에 lb-p22 균주 및 이를 포함하는 만성신장질환 예방, 개선 또는 치료용 조성물

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4147773A (en) *	1977-12-12	1979-04-03	Morinaga Milk Industry Co., Ltd.	Powdery composition comprising viable Bifidobacteria cells and lactulose
JPS5649154A (en)	1979-09-26	1981-05-02	Morishita Jintan Co	Manufacture of capsule that can continuously masssproduce ultramicroocapsule and its manufacturing device
JP2999535B2 (ja)	1990-09-27	2000-01-17	保土谷化学工業株式会社	水面直接施用農薬カプセル剤
CA2127392C (en) *	1993-07-08	2008-05-27	Hideki Sunohara	Process for producing capsule and capsule obtained thereby
JP4156684B2 (ja)	1996-03-05	2008-09-24	三菱化学株式会社	高リン血症予防および／または治療剤
EP0793960B1 (en) *	1996-03-05	2001-08-01	Mitsubishi Chemical Corporation	Use of anion exchange resins for the manufacture of a medicament for the treatment of hyperphosphatemia
IT1288119B1 (it) *	1996-06-28	1998-09-10	Renata Maria Anna Ve Cavaliere	Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
JPH11199495A (ja) *	1998-01-10	1999-07-27	Nichinichi Seiyaku Kk	腸溶性カプセルを用いた抗アレルギー剤
JP2000026304A (ja) *	1998-07-13	2000-01-25	Crescendo Corporation:Kk	ビフィズス菌による運動能力の向上
JP2000154143A (ja) *	1999-01-01	2000-06-06	Rna Kenkyusho Kk	高脂血症改善剤
JP4473976B2 (ja)	1999-06-03	2010-06-02	焼津水産化学工業株式会社	血中リン濃度低下剤
JP4001443B2 (ja)	1999-06-24	2007-10-31	日清紡績株式会社	リン吸収阻害剤及びそれを含む治療剤
JP2001048791A (ja)	1999-08-10	2001-02-20	Hisamitsu Pharmaceut Co Inc	高リン血症予防および／または治療剤
AU2001241095A1 (en)	2000-03-13	2001-09-24	Hisamitsu Pharmaceutical Co. Inc.	Preventives and/or remedies for hyperphosphatemia
JP2003012526A (ja) *	2001-06-27	2003-01-15	Sunstar Inc	有用生菌内包製剤
JP3665616B2 (ja)	2002-02-07	2005-06-29	ポーラ化成工業株式会社	ローヤルゼリー製剤
EP1492549B1 (en) *	2002-03-13	2016-05-11	Kibow Biotech, Inc.	Compositions and methods for augmenting kidney function
CN1668319A (zh) *	2002-07-09	2005-09-14	德森特沃克公司	整肠性组合物、整肠健康饮料以及大肠内清洗液
US20050266069A1 (en) *	2002-09-06	2005-12-01	Simmons Donald L	Stable probiotic microsphere compositions and their methods of preparation
JP2004277296A (ja) *	2003-03-13	2004-10-07	Morishita Jintan Kk	乳酸菌含有腸溶性製剤
US8871266B2 (en) *	2003-10-01	2014-10-28	Commonwealth Scientific & Industrial Research Organisation	Probiotic storage and delivery
US20060093592A1 (en) *	2004-10-04	2006-05-04	Nutracea	Synbiotics
JP2006176450A (ja) *	2004-12-22	2006-07-06	Hiroshima Univ	小腸でのリンの過剰吸収を抑制可能とする乳酸菌含有組成物
JP4889970B2 (ja)	2005-07-20	2012-03-07	太陽化学株式会社	高リン血症用製剤
CN100482104C (zh) *	2006-07-07	2009-04-29	山东省农业科学院高新技术研究中心	一种乳酸菌口服液的制备方法

2008
- 2008-03-19 JP JP2008072218A patent/JP5487379B2/ja active Active
2009
- 2009-03-02 JP JP2010503820A patent/JPWO2009116382A1/ja active Pending
- 2009-03-02 ES ES09721660.0T patent/ES2443293T3/es active Active
- 2009-03-02 WO PCT/JP2009/053837 patent/WO2009116382A1/ja not_active Ceased
- 2009-03-02 KR KR1020107023226A patent/KR101657066B1/ko active Active
- 2009-03-02 CN CN2009801098451A patent/CN101977615B/zh active Active
- 2009-03-02 EP EP09721660.0A patent/EP2281567B1/en active Active
- 2009-03-02 CA CA2716676A patent/CA2716676C/en active Active
- 2009-03-02 BR BRPI0909692-2A patent/BRPI0909692A2/pt not_active IP Right Cessation
- 2009-03-02 US US12/919,344 patent/US20110002902A1/en not_active Abandoned
- 2009-03-18 TW TW098108698A patent/TWI489987B/zh active
2012
- 2012-11-29 US US13/688,640 patent/US9056122B2/en active Active

Also Published As

Publication number	Publication date
KR20100126521A (ko)	2010-12-01
JPWO2009116382A1 (ja)	2011-08-04
CA2716676A1 (en)	2009-09-24
CA2716676C (en)	2016-12-13
ES2443293T3 (es)	2014-02-18
EP2281567A1 (en)	2011-02-09
TW200944216A (en)	2009-11-01
CN101977615B (zh)	2012-11-21
US20130089531A1 (en)	2013-04-11
US9056122B2 (en)	2015-06-16
WO2009116382A1 (ja)	2009-09-24
KR101657066B1 (ko)	2016-09-13
TWI489987B (zh)	2015-07-01
US20110002902A1 (en)	2011-01-06
EP2281567B1 (en)	2013-12-04
EP2281567A4 (en)	2012-04-11
CN101977615A (zh)	2011-02-16
JP2011148703A (ja)	2011-08-04
JP5487379B2 (ja)	2014-05-07

Publication	Publication Date	Title
BRPI0909692A2 (pt)	2018-06-26	inibidor da elevação do nível de fosfóro no sangue
WO2009117482A8 (en)	2010-04-08	Mtor inhibitor salt forms
UA89220C2 (ru)	2010-01-11	Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы
EA201270803A1 (ru)	2013-05-30	Тиоацетатные соединения, композиции на их основе и способы их применения
WO2012058645A8 (en)	2012-06-28	Heterocyclic tyrosine kinase inhibitors
EA201200559A1 (ru)	2012-10-30	Способы назначения терапии пирфенидоном
WO2011123719A3 (en)	2011-12-15	Use of faah inhibitors for treating abdominal, visceral and pelvic pain
TN2012000543A1 (en)	2014-04-01	Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
AR081681A1 (es)	2012-10-10	METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA
WO2011045703A3 (en)	2011-06-16	C-linked hydroxamic acid derivatives useful as antibacterial agents
EP3354640A3 (en)	2018-10-31	Mif inhibitors and their uses
MX349787B (es)	2017-08-11	Formas de dosis oral que incluyen un agente antiplaqueta y un inhibidor de ácido.
CL2016002589A1 (es)	2017-05-19	Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
WO2017019429A8 (en)	2018-02-01	7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant idh1 inhibitors
WO2011159840A3 (en)	2012-04-05	Phenylthioacetate compounds, compositions and methods of use
WO2011113798A3 (en)	2011-11-17	Inhibitors of semicarabazide - sensitive amine oxidase
EA201170680A1 (ru)	2011-12-30	Ингибиторы акт и p70 s6-киназы
EP3409666A3 (en)	2019-01-02	Seca inhibitors and methods of making and using thereof
TNSN08178A1 (en)	2009-10-30	Triazolopyridine derivatives as inhibitors of lipases and phospholipases
UA111148C2 (uk)	2016-04-11	Сигма-ліганди для застосування при профілактиці і/або лікуванні післяопераційного болю
MX2014003025A (es)	2014-05-28	Compuestos de triazolopiridina como inhibidores de fosfodiesterasa 10a.
WO2009067856A8 (zh)	2010-06-03	组蛋白去乙酰化酶抑制剂及其制备和用途
TW200722421A (en)	2007-06-16	Azole derivatives as inhibitors of lipases and phospholipases
WO2012158672A3 (en)	2014-05-08	Compounds for use in treatment of mucositis
EP2792693A4 (en)	2015-11-04	FLUORATED COPOLYMER AND WATER- / OIL-REPELLENT MEDIUM WITH THIS COPOLYMER AS AN ACTIVE SUBSTANCE

Legal Events

Date	Code	Title	Description
2018-07-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2019-12-03	B07G	Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
2019-12-31	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]	Free format text: REFERENTE A 11A ANUIDADE.
2020-07-07	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2556 DE 31/12/2019.
2021-08-24	B350	Update of information on the portal [chapter 15.35 patent gazette]